Off-label prescribing for oncology treatments and use of supportive care drugs may see some changes as a result of the Medicare Oncology Care Model, a large-scale experiment testing a new approach to payments for cancer care treatments and services now underway and involving more than 3,200 oncologists and about 155,000 beneficiaries nationwide.
Launched July 1, the model is a five-year modified bundling experiment aimed at improving the quality of care and lowering...






